MobiHealth News June 19, 2020
The executives also share details about what patients can expect from the G7 next year.
When it comes to the diabetes space, Dexcom is one of the heavy hitters. Its work in the continuous glucose monitoring space has put it on the map. In 2018, its Dexcom G6, an integrated continuous glucose monitoring system, got the greenlight from the FDA, making it the first interoperable CGM to get the designation. This means that it could be part of an integrated system compatible with other devices, which include automated insulin dosing systems, insulin pumps and blood glucose meters.
While personal CGMs for diabetes patients have been the staple of Dexcom’s business, as it moves into the next decade the company...
Today's Sponsors
Today's Sponsor